Illumina Feb 24, 2026 Illumina launches TruPath Genome, setting a new standard in genomic insight - Illumina
Illumina Feb 24, 2026 Illumina's TruPath Genome offers rapid whole genome testing for rare disease - Stock Titan
Illumina Feb 24, 2026 Illumina launches TruPath Genome, setting a new standard in genomic insight - PR Newswire
Illumina Feb 24, 2026 Next Generation Sequencing Market Competitive Landscape Report 2025 Featuring Top Players - Thermo Fisher Scientific, Pacific Biosciences, Illumina, Roche - Yahoo Finance Singapore
Illumina Feb 24, 2026 The Bull Case For Illumina (ILMN) Could Change Following Buybacks And NovaSeq X Roadmap Reveal – Learn Why - simplywall.st
Illumina Feb 23, 2026 Illumina, Inc. (ILMN) Stock Analysis: Exploring a 15.62% Potential Upside in the Genomics Sector - DirectorsTalk Interviews
Illumina Feb 23, 2026 Faster DNA decoding: Illumina’s NovaSeq X gets 40% more data, higher accuracy - Stock Titan
Illumina Feb 23, 2026 Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility - PR Newswire
Illumina Feb 23, 2026 Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility - Illumina
Illumina Feb 21, 2026 Illumina Beat Q4 Earnings and Closed a $350M Acquisition. Here’s What Investors Need to Know - TIKR.com
Illumina Feb 19, 2026 Scrappy San Diego startup goes toe-to-toe with gene-sequencing giant Illumina - San Diego Union-Tribune
Illumina Feb 19, 2026 Is It Time To Reassess Illumina (ILMN) After Recent Share Price Volatility - Yahoo Finance
Illumina Feb 18, 2026 Illumina Stock is Down 80% From Its All-Time Highs: Can It Recover in 2026? - TIKR.com
Illumina Feb 17, 2026 A Look At Illumina (ILMN) Valuation After Profitability Gains And SomaLogic Acquisition Guidance - simplywall.st